Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer: Update 2022
Year: 2024
Type: article
Abstract: Patients with early-stage nasopharyngeal cancer are treated with definitive radiotherapy alone, including both sides of the neck and retropharyngeal nodes. For patients with locoregionally advanced nasopharyngeal cancer, the recommendation is concurrent chemoradiotherapy with additional chemotherapy (either before or after chemoradiotherapy). Adding targeted therapies like nimotuzumab to concurrent chemoradiation in the management of nasopharyngeal cancer has been shown to improve overall survival with excellent safety and tolerability.
Authors: Munish Gairola, Kumar Prabhash, K Govind Babu, Pankaj Chaturvedi, Moni Kuriakose, Praveen Birur, Anil K. Anand, Ashish Kaushal, Abhishek Mahajan, Judita Syiemlieh, Manish Singhal, Prakash Ramachandra, Sumit Goyal, Subashini John, Rohit Nayyar, Vijay M. Patil, Vishal Rao, Vanita Noronha, Vikas Roshan, G.K. Rath
Institutions: Rajiv Gandhi Cancer Institute and Research Centre, Tata Memorial Hospital, Mazumdar Shaw Medical Centre, Fortis Memorial Research Institute, Clatterbridge Cancer Centre NHS Foundation Trust, Indraprastha Apollo Hospitals, Sri Shankara Cancer Hospital and Research Center, Christian Medical College, Vellore, Max Super Speciality Hospital, P. D. Hinduja Hospital and Medical Research Centre, HCG Cancer Centre, Healthcare Global Enterprises, All India Institute of Medical Sciences
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4390919800